Boston, MA -- (SBWIRE) -- 08/15/2013 -- Global Markets Direct's pharmaceuticals report, "Lycera Corp. - Product Pipeline Review - 2013" provides data on the Lycera Corp.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Lycera Corp.'s corporate website, SEC filings, investor presentations and featured press releases, both from Lycera Corp. and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Lycera Corp. - Brief Lycera Corp. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Lycera Corp. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Lycera Corp. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Lycera Corp.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Lycera Corp.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Lycera Corp. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Lycera Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Lycera Corp..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Lycera Corp. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Chong Kun Dang Pharmaceutical Corp. - Product Pipeline Review - 2013
- Lycera Corp. - Product Pipeline Review - 2012
- IntelGenx Corp. - Product Pipeline Review - 2013
- Angion Biomedica Corp. - Product Pipeline Review - 2013
- Synageva BioPharma Corp. - Product Pipeline Review - 2013
- Resverlogix Corp. - Product Pipeline Review - 2013
- Anavex Life Sciences Corp. - Product Pipeline Review - 2013
- Targa Therapeutics Corp. - Product Pipeline Review - 2013
- Osmotica Pharmaceutical Corp. - Product Pipeline Review - 2013
- Immune Design Corp. - Product Pipeline Review - 2013